Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal cellular physiology (HP:0011017)help
Grandparent Node:
expand
Abnormal lymphocyte physiology (HP:0031409)help
Parent Node:
expand
Abnormality of T cell physiology (HP:0011840)help
..Starting node
..expand
Impaired T cell function (HP:0005435)help
Term ID: 5435
Name: Impaired T cell function
Synonym: Impaired T cell function; T-cell dysfunction
Definition: Abnormally reduced ability of T cells to perform their functions in cell-mediated immunity.
Comments:
Reference: HP:0005435
Genes and Diseases:
 
       Child Nodes:
........expandDefective T cell proliferation (HP:0030253) help

 Sister Nodes: 
..expandAbnormal delayed hypersensitivity skin test (HP:0002963) help
..expandAbnormal T cell activation (HP:0410035) help
..expandAbnormal T cell proliferation (HP:0031379) help
..expandLack of T cell function (HP:0005354) help
..expandobsolete Exaggerated cellular immune processes (HP:0005397) help
..expandOligoclonal T cell expansion (HP:0031430) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0005435HP:0005435Impaired T cell function0AK2 CL E G H204362OMIM:267500Reticular dysgenesia.19
HP:0005435HP:0005435Impaired T cell function0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent1
HP:0005435HP:0005435Impaired T cell function0CD19 CL E G H9301633OMIM:240500Immunodeficiency, common variable, 2.38
HP:0005435HP:0005435Impaired T cell function0CD3E CL E G H9161674OMIM:615615Immunodeficiency 1824
HP:0005435HP:0005435Impaired T cell function0COG6 CL E G H5751118621OMIM:614576CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L71
HP:0005435HP:0005435Impaired T cell function0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent6
HP:0005435HP:0005435Impaired T cell function0CR2 CL E G H13802336OMIM:240500Immunodeficiency, common variable, 2.10
HP:0005435HP:0005435Impaired T cell function0CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0005435HP:0005435Impaired T cell function0DGCR2 CL E G H99932845OMIM:192430Velocardiofacial syndrome
HP:0005435HP:0005435Impaired T cell function0DGCR6 CL E G H82142846OMIM:192430Velocardiofacial syndrome
HP:0005435HP:0005435Impaired T cell function0DGCR8 CL E G H544872847OMIM:192430Velocardiofacial syndrome
HP:0005435HP:0005435Impaired T cell function0ESS2 CL E G H822016817OMIM:192430Velocardiofacial syndrome
HP:0005435HP:0005435Impaired T cell function0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent8
HP:0005435HP:0005435Impaired T cell function0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent3
HP:0005435HP:0005435Impaired T cell function0ICOS CL E G H298515351OMIM:607594Immunodeficiency, common variable, 1.32
HP:0005435HP:0005435Impaired T cell function0ICOS CL E G H298515351OMIM:240500Immunodeficiency, common variable, 2.32
HP:0005435HP:0005435Impaired T cell function0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent2
HP:0005435HP:0005435Impaired T cell function0LIG1 CL E G H39786598OMIM:619774IMMUNODEFICIENCY 96; IMD969
HP:0005435HP:0005435Impaired T cell function0MRTFA CL E G H5759114334OMIM:618847IMMUNODEFICIENCY 66; IMD66
HP:0005435HP:0005435Impaired T cell function0PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency.52
HP:0005435HP:0005435Impaired T cell function0RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0005435HP:0005435Impaired T cell function0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0005435HP:0005435Impaired T cell function0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0005435HP:0005435Impaired T cell function0SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type.55
HP:0005435HP:0005435Impaired T cell function0SMARCAL1 CL E G H5048511102ORPHA:1830Schimke immuno-osseous dysplasiaHP:0040282 - Frequent74
HP:0005435HP:0005435Impaired T cell function0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent32
HP:0005435HP:0005435Impaired T cell function0TBX1 CL E G H689911592OMIM:188400Digeorge syndrome.32
HP:0005435HP:0005435Impaired T cell function0TBX1 CL E G H689911592OMIM:192430Velocardiofacial syndrome32
HP:0005435HP:0005435Impaired T cell function0TGFB1 CL E G H704011766OMIM:618213INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE13
HP:0005435HP:0005435Impaired T cell function0TNFRSF13B CL E G H2349518153OMIM:240500Immunodeficiency, common variable, 2.32
HP:0005435HP:0005435Impaired T cell function0TNFRSF13C CL E G H11565017755OMIM:240500Immunodeficiency, common variable, 2.12
HP:0005435HP:0005435Impaired T cell function0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040282 - Frequent
HP:0005435HP:0005435Impaired T cell function0UMPS CL E G H737212563ORPHA:30Hereditary orotic aciduriaHP:0040282 - Frequent135
HP:0005435HP:0005435Impaired T cell function0UMPS CL E G H737212563OMIM:258900Orotic aciduriaHP:0040283 - Occasional135
HP:0005435HP:0005435Impaired T cell function0WIPF1 CL E G H745612736OMIM:614493WISKOTT-ALDRICH SYNDROME 2; WAS26
HP:0005435HP:0030253Defective T cell proliferation1CD3E CL E G H9161674OMIM:615615Immunodeficiency 18HP:0040283 - Occasional24
HP:0005435HP:0030253Defective T cell proliferation1CTPS1 CL E G H15032519OMIM:615897IMMUNODEFICIENCY 24; IMD242
HP:0005435HP:0030253Defective T cell proliferation1LIG1 CL E G H39786598OMIM:619774IMMUNODEFICIENCY 96; IMD969
HP:0005435HP:0030253Defective T cell proliferation1MRTFA CL E G H5759114334OMIM:618847IMMUNODEFICIENCY 66; IMD66
HP:0005435HP:0030253Defective T cell proliferation1RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0005435HP:0030253Defective T cell proliferation1TGFB1 CL E G H704011766OMIM:618213INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE13
HP:0005435HP:0030253Defective T cell proliferation1WIPF1 CL E G H745612736OMIM:614493WISKOTT-ALDRICH SYNDROME 2; WAS26


Genes (31) :AK2 ARVCF CD19 CD3E COG6 COMT CR2 CTPS1 DGCR2 DGCR6 DGCR8 ESS2 GP1BB HIRA ICOS JMJD1C LIG1 MRTFA PNP RASGRP1 RREB1 SEC24C SLC39A4 SMARCAL1 TBX1 TGFB1 TNFRSF13B TNFRSF13C UFD1 UMPS WIPF1

Diseases (19) :OMIM:267500 ORPHA:567 OMIM:240500 OMIM:615615 OMIM:614576 OMIM:615897 OMIM:192430 OMIM:607594 OMIM:619774 OMIM:618847 OMIM:613179 OMIM:618534 OMIM:201100 ORPHA:1830 OMIM:188400 OMIM:618213 ORPHA:30 OMIM:258900 OMIM:614493
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.